Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

Current Status and Future Directions for Screening Patients at High Risk for Pancreatic Cancer.

McAllister F, Montiel MF, Uberoi GS, Uberoi AS, Maitra A, Bhutani MS.

Gastroenterol Hepatol (N Y). 2017 May;13(5):268-275.

2.

Familial pancreatic cancer: Concept, management and issues.

Matsubayashi H, Takaori K, Morizane C, Maguchi H, Mizuma M, Takahashi H, Wada K, Hosoi H, Yachida S, Suzuki M, Usui R, Furukawa T, Furuse J, Sato T, Ueno M, Kiyozumi Y, Hijioka S, Mizuno N, Terashima T, Mizumoto M, Kodama Y, Torishima M, Kawaguchi T, Ashida R, Kitano M, Hanada K, Furukawa M, Kawabe K, Majima Y, Shimosegawa T.

World J Gastroenterol. 2017 Feb 14;23(6):935-948. doi: 10.3748/wjg.v23.i6.935. Review.

3.

Estimating TP53 Mutation Carrier Probability in Families with Li-Fraumeni Syndrome Using LFSPRO.

Peng G, Bojadzieva J, Ballinger ML, Li J, Blackford AL, Mai PL, Savage SA, Thomas DM, Strong LC, Wang W.

Cancer Epidemiol Biomarkers Prev. 2017 Jun;26(6):837-844. doi: 10.1158/1055-9965.EPI-16-0695. Epub 2017 Jan 30.

4.

Screening for Pancreatic Cancer.

Ngamruengphong S, Canto MI.

Surg Clin North Am. 2016 Dec;96(6):1223-1233. doi: 10.1016/j.suc.2016.07.016. Review.

5.

Genetic evaluation and testing for hereditary forms of cancer in the era of next-generation sequencing.

Stanislaw C, Xue Y, Wilcox WR.

Cancer Biol Med. 2016 Mar;13(1):55-67. doi: 10.28092/j.issn.2095-3941.2016.0002.

6.

Advances in Hereditary Colorectal and Pancreatic Cancers.

Underhill ML, Germansky KA, Yurgelun MB.

Clin Ther. 2016 Jul;38(7):1600-21. doi: 10.1016/j.clinthera.2016.03.017. Epub 2016 Apr 2. Review.

7.

The role of endoscopic ultrasound in pancreatic cancer screening.

Bhutani MS, Koduru P, Joshi V, Saxena P, Suzuki R, Irisawa A, Yamao K.

Endosc Ultrasound. 2016 Jan-Feb;5(1):8-16. doi: 10.4103/2303-9027.175876.

8.

A two-stage approach to genetic risk assessment in primary care.

Biswas S, Atienza P, Chipman J, Blackford AL, Arun B, Hughes K, Parmigiani G.

Breast Cancer Res Treat. 2016 Jan;155(2):375-83. doi: 10.1007/s10549-016-3686-2. Epub 2016 Jan 19.

9.

Implications and issues related to familial pancreatic cancer: a cohort study of hospitalized patients.

Mughetti M, Calculli L, Chiesa AM, Ciccarese F, Rrusho O, Pezzilli R.

BMC Gastroenterol. 2016 Jan 15;16:6. doi: 10.1186/s12876-016-0421-8.

10.

Development and Validation of a Prediction Model to Estimate Individual Risk of Pancreatic Cancer.

Yu A, Woo SM, Joo J, Yang HR, Lee WJ, Park SJ, Nam BH.

PLoS One. 2016 Jan 11;11(1):e0146473. doi: 10.1371/journal.pone.0146473. eCollection 2016.

11.

Early detection of pancreatic cancer.

Kim VM, Ahuja N.

Chin J Cancer Res. 2015 Aug;27(4):321-31. doi: 10.3978/j.issn.1000-9604.2015.07.03. Review.

12.

Identification of Patients with Family History of Pancreatic Cancer--Investigation of an NLP System Portability.

Mehrabi S, Krishnan A, Roch AM, Schmidt H, Li D, Kesterson J, Beesley C, Dexter P, Schmidt M, Palakal M, Liu H.

Stud Health Technol Inform. 2015;216:604-8.

13.

Screening for pancreatic cancer in familial high-risk individuals: A systematic review.

Lu C, Xu CF, Wan XY, Zhu HT, Yu CH, Li YM.

World J Gastroenterol. 2015 Jul 28;21(28):8678-86. doi: 10.3748/wjg.v21.i28.8678. Review.

14.

Establishing a clinic-based pancreatic cancer and periampullary tumour research registry in Quebec.

Smith AL, Bascuñana C, Hall A, Salman A, Andrei AZ, Volenik A, Rothenmund H, Ferland D, Lamoussenery D, Kamath AS, Amre R, Caglar D, Gao ZH, Haegert DG, Kanber Y, Michel RP, Omeroglu-Altinel G, Asselah J, Bouganim N, Kavan P, Arena G, Barkun J, Chaudhury P, Gallinger S, Foulkes WD, Omeroglu A, Metrakos P, Zogopoulos G.

Curr Oncol. 2015 Apr;22(2):113-21. doi: 10.3747/co.22.2300.

15.

Pancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parameters.

Urayama S.

World J Gastroenterol. 2015 Feb 14;21(6):1707-17. doi: 10.3748/wjg.v21.i6.1707. Review.

16.

ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes.

Syngal S, Brand RE, Church JM, Giardiello FM, Hampel HL, Burt RW; American College of Gastroenterology.

Am J Gastroenterol. 2015 Feb;110(2):223-62; quiz 263. doi: 10.1038/ajg.2014.435. Epub 2015 Feb 3. Review.

17.

High-risk population in sporadic pancreatic adenocarcinoma: guidelines for screening.

Bruenderman EH, Martin RC 2nd.

J Surg Res. 2015 Mar;194(1):212-9. doi: 10.1016/j.jss.2014.06.046. Epub 2014 Oct 13. Review.

18.

Genetic predisposition to pancreatic cancer.

Ghiorzo P.

World J Gastroenterol. 2014 Aug 21;20(31):10778-89. doi: 10.3748/wjg.v20.i31.10778. Review.

19.

Endoscopic ultrasonography for surveillance of individuals at high risk for pancreatic cancer.

Lami G, Biagini MR, Galli A.

World J Gastrointest Endosc. 2014 Jul 16;6(7):272-85. doi: 10.4253/wjge.v6.i7.272. Review.

20.

The early detection of pancreatic cancer: what will it take to diagnose and treat curable pancreatic neoplasia?

Lennon AM, Wolfgang CL, Canto MI, Klein AP, Herman JM, Goggins M, Fishman EK, Kamel I, Weiss MJ, Diaz LA, Papadopoulos N, Kinzler KW, Vogelstein B, Hruban RH.

Cancer Res. 2014 Jul 1;74(13):3381-9. doi: 10.1158/0008-5472.CAN-14-0734. Epub 2014 Jun 12. Review.

Supplemental Content

Support Center